China SXT Pharmaceuticals Inc (SXTC)
0.40
+0.02
(+4.44%)
USD |
NASDAQ |
Nov 25, 16:00
0.383
-0.02
(-4.25%)
After-Hours: 20:00
China SXT Pharmaceuticals Debt to Equity Ratio: 0.1731 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.1731 |
| September 30, 2023 | 0.5693 |
| March 31, 2023 | 0.2349 |
| September 30, 2022 | 0.081 |
| March 31, 2022 | 0.1246 |
| September 30, 2021 | 0.0017 |
| March 31, 2021 | 0.0027 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0033 |
| March 31, 2020 | 0.7152 |
| September 30, 2019 | 0.5185 |
| March 31, 2019 | 0.0273 |
| September 30, 2018 | 0.0486 |
| March 31, 2018 | 0.1172 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0017
Minimum
Sep 2021
0.7152
Maximum
Mar 2020
0.2118
Average
0.1246
Median
Mar 2022
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0358 |
| CASI Pharmaceuticals Inc | 1.381 |
| Zai Lab Ltd | 0.1692 |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 23.13M |
| Total Liabilities (Quarterly) | 9.197M |
| Shareholders Equity (Quarterly) | 13.93M |
| Current Ratio | 1.599 |
| Net Debt Paydown Yield | -10.78% |